Zhang Ping
SEC insider (Form 3/4/5 filer). CIK 0002050176. Director at GYRE THERAPEUTICS, INC. (GYRE). 5 reported Form 4/5 transactions since Sep 2024; latest on May 14, 2026. Located in SAN DIEGO, CA.
Companies Zhang Ping has filed insider reports for
- GYRE THERAPEUTICS, INC. (GYRE): Director
Zhang Ping
CIK: 0002050176
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GYRE THERAPEUTICS, INC.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- May 14, 2026GYRE
GYRE THERAPEUTICS, INC.
DispositionDirectStock Option (Right to Buy)
250K shares- - Jan 7, 2026GYRE
GYRE THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
100K shares- - Aug 5, 2025GYRE
GYRE THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
250K shares- - May 27, 2025GYRE
GYRE THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
250K shares- - Jan 5, 2025GYRE
GYRE THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
52K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 14, 2026 | GYRE GYRE THERAPEUTICS, INC. | Disposition Stock Option (Right to Buy) | 250,000 | - | - | Direct |
| Jan 7, 2026 | GYRE GYRE THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 100,000 | - | - | Direct |
| Aug 5, 2025 | GYRE GYRE THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 250,000 | - | - | Direct |
| May 27, 2025 | GYRE GYRE THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 250,000 | - | - | Direct |
| Jan 5, 2025 | GYRE GYRE THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 52,000 | - | - | Direct |
1-5 of 5 transactions